A Comparative Study Between Ultrasound Guided Erector Spinae Plane Block and Combined Ultrasound … (NCT06402006) | Clinical Trial Compass
CompletedNot Applicable
A Comparative Study Between Ultrasound Guided Erector Spinae Plane Block and Combined Ultrasound Guided Pericapsular Nerve Group and Lateral Femoral Nerve Block Following Total Hip Arthroplasty
Egypt50 participantsStarted 2024-05-15
Plain-language summary
The patients will be randomized into 2 equal groups by a computer-generated random numbers table, named group A, B.
Group A: patients will receive Pericapsular nerve group block and lateral femoral cutaneous nerve blocks.
Group B: Patients will receive Erector spinae plane block.
After IV access insertion and oxygen nasal cannula application, monitoring will be applied for all patients, sedation in the form of midazolam 0.02mg/kg with or without fentanyl 0.5-1 mcg/kg will be administered to any of the patients who felt discomfort or could not tolerate the procedure.
For (Group A) PENG block will be done before spinal anesthesia.
LFCN block will be performed.
For (Group B), ESP block will be done before spinal anesthesia.
Spinal anesthesia will be chosen as the main anesthetic technique.
In postoperative period all patients will receive the same adjuvant multimodal analgesia which will be 1000 mg of paracetamol with or without 30 mg ketorolac depending on comorbidities and depending on the patients" needs.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Patients American Society of anesthesiologists' physical status (ASA) I to III.
. Aged 18 to 65 years.
. Both sexes.
. Patients scheduled for total hip arthroplasty.
Exclusion criteria
. Patient refusal
. ASA physical status III or more.
. Patients with known allergy to any of the study drugs.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
individual visual analog pain scores at 0, 6, 12, 24 and 48 h postoperatively (VAS; 0 = no pain and 10 = worst pain imaginable).
Timeframe: 48 hours
2
presence of moderate-to-severe pain, defined as pain score 4 or greater during the first 48 h postoperative.
Timeframe: 48 hours
3
analgesic consumption in post-anesthesia care unit, and during the first 48 h post-surgery (converted to IV pethidine equivalents).